Table 2.
Outcomes within 30 days of diagnosis
| Outcomes | Total (n=40) | HBO2
(n=20) |
Control (n=20) | P value | Effect size (95% CI) |
| Days to normalisation* | 5.0 (3.0; 9.0) | 3.0 (1.0; 4.5) | 9.0 (5.5; 12.5) | <0.010 | HR 6.9 (2.9 to 16.2) |
| SpO2 ≥93% at 3 days, n (%) | 12 (30) | 11 (55) | 1 (8) | 0.001 | OR 23.2 (1.6 to 329.6) |
| SpO2 ≥93% at 5 days, n (%) | 27 (68) | 19 (95) | 8 (40) | <0.001 | OR 28.5 (1.8 to 447.4) |
| SpO2 ≥93% at 10 days, n (%) | 33 (83) | 20 (100) | 13(65) | 0.004 | ∞ |
| SpO2 ≥93% at 15 days, n (%) | 36 (90) | 20 (100) | 16 (80) | 0.106 | ∞ |
| Acute respiratory distress, n (%) | 4 (10) | 1 (5) | 3 (15) | 0.605 | OR 0.3 (0.0 to 3.4) |
| Mechanical ventilation, n (%) | 4 (10) | 1 (5) | 3 (15) | 0.605 | OR 0.3 (0.0 to 3.4) |
| Death, n (%) | 2 (5) | 1 (5) | 1 (5) | 1.000 | OR 1.0 (0.1 to 17.8) |
* Median (25th percentile; 75th percentile).
SpO2, oxygen saturation.